BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15948136)

  • 1. Lymphatic vessel density and lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Horvath LG; Sutherland RL; Williams ED
    Prostate; 2005 Nov; 65(3):222-30. PubMed ID: 15948136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.
    Adachi Y; Nakamura H; Kitamura Y; Taniguchi Y; Araki K; Shomori K; Horie Y; Kurozawa Y; Ito H; Hayashi K
    Pathol Int; 2007 Apr; 57(4):171-7. PubMed ID: 17316411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
    Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
    J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic vessel densities of lymph node-negative prostate adenocarcinoma in Korea.
    Kim HS; Sung W; Lee S; Chang SG; Park YK
    Pathol Res Pract; 2009; 205(4):249-54. PubMed ID: 19058917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients.
    Chen Z; Wang T; Luo H; Lai Y; Yang X; Li F; Lei Y; Su C; Zhang X; Lahn BT; Xiang AP
    Hum Pathol; 2010 May; 41(5):737-44. PubMed ID: 20132963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
    Fukunaga S; Maeda K; Noda E; Inoue T; Wada K; Hirakawa K
    Oncology; 2006; 71(3-4):204-11. PubMed ID: 17641542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological study of lymphatic vessel density and distribution in pancreatic cancer].
    Jin G; Hu XG; Liu R; Zhang YJ; Shao CH; Tang Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):583-6. PubMed ID: 16274037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma.
    Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral but not peritumoral lymphatic vessel density measured by D2-40 expression predicts poor outcome in gastric cancer--ROC curve analysis to find cut-off point.
    Donizy P; Rudno-Rudzinska J; Halon A; Dziegala M; Kabarowski J; Frejlich E; Dziegiel P; Kielan W; Matkowski R
    Anticancer Res; 2014 Jun; 34(6):3113-8. PubMed ID: 24922680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
    Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
    Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.
    Jennbacken K; Vallbo C; Wang W; Damber JE
    Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma.
    Baek SK; Jung KY; Lee SH; Woo JS; Kwon SY; Chung EJ; Kim TH; Chae YS
    Laryngoscope; 2009 Jul; 119(7):1325-30. PubMed ID: 19444880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity.
    Baldewijns MM; Roskams T; Ballet V; Van den Eynden GG; Van Laere SJ; Van der Auwera I; Lerut E; De Bruïne AP; Thijssen VL; Vermeulen PB; van Poppel H
    BJU Int; 2009 Jun; 103(12):1626-31. PubMed ID: 19154467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.